StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3569
This month
66
This week
17
This year
302
Today
7
Yesterday
9
Publishing Date
2024 - 04 - 18
7
2024 - 04 - 16
4
2024 - 04 - 15
4
2024 - 04 - 11
4
2024 - 04 - 09
8
2024 - 04 - 08
7
2024 - 04 - 05
4
2024 - 04 - 04
5
2024 - 04 - 02
9
2024 - 04 - 01
6
2024 - 03 - 28
3
2024 - 03 - 27
5
2024 - 03 - 26
6
2024 - 03 - 25
8
2024 - 03 - 22
5
2024 - 03 - 21
3
2024 - 03 - 20
4
2024 - 03 - 19
5
2024 - 03 - 15
3
2024 - 03 - 14
4
2024 - 03 - 13
5
2024 - 03 - 12
6
2024 - 03 - 11
3
2024 - 03 - 07
6
2024 - 03 - 06
7
2024 - 03 - 05
9
2024 - 03 - 04
3
2024 - 02 - 29
3
2024 - 02 - 27
7
2024 - 02 - 26
5
2024 - 02 - 23
6
2024 - 02 - 22
7
2024 - 02 - 21
3
2024 - 02 - 15
3
2024 - 02 - 14
7
2024 - 02 - 13
2
2024 - 02 - 12
4
2024 - 02 - 08
4
2024 - 02 - 07
6
2024 - 02 - 06
3
2024 - 02 - 05
5
2024 - 02 - 02
2
2024 - 01 - 31
7
2024 - 01 - 30
6
2024 - 01 - 29
8
2024 - 01 - 26
2
2024 - 01 - 25
2
2024 - 01 - 24
2
2024 - 01 - 23
2
2024 - 01 - 22
4
2024 - 01 - 18
7
2024 - 01 - 17
4
2024 - 01 - 16
2
2024 - 01 - 11
2
2024 - 01 - 10
5
2024 - 01 - 09
4
2024 - 01 - 08
7
2024 - 01 - 04
5
2024 - 01 - 03
2
2024 - 01 - 02
3
Sector
Commercial services
8
Communications
3
Consumer durables
3
Consumer non-durables
1
Consumer services
3
Distribution services
2
Electronic technology
1
Energy minerals
2
Finance
22
Finance and insurance
3
Health care and social assistance
2
Health services
1
Health technology
158
Industrial services
1
Information
3
Manufacturing
26
Mining, quarrying, and oil and gas extraction
2
N/a
18
Non-energy minerals
4
Process industries
3
Producer manufacturing
4
Professional, scientific, and technical services
4
Retail trade
2
Technology services
9
Utilities
1
Tags
Advanced
4
Antibody
4
Application
6
Biopharma
5
Breast
4
Business
4
Cancer
17
Cell
8
China
4
Chmp
10
Clinical-trials-phase-ii
6
Clinical-trials-phase-iii
9
Company
7
Conference
4
Covid-19
4
Disease
12
Drug
4
Expansion
4
Fda
8
Fibromyalgia
4
Financial
11
First
8
Flow
5
For
19
Gartner
4
Global
4
Growth
11
Japan
4
Key
5
Lung
8
Management
4
Market
10
Medical
4
Meeting
17
Million
9
N/a
233
Nasdaq
12
Obesity
4
Pharm-country
5
Pharma
7
Pharmaceuticals
18
Positive
214
Preclinical
9
Program
10
Publication
6
Report
7
Research
32
Results
80
Revenue
5
Study
62
System
7
Technology
5
Therapeutics
40
Therapy
13
Topline
34
Treatment
33
Trial
63
Tumors
8
Update
5
Year
10
Entities
4d molecular therapeutics inc
1
Abbvie inc.
3
Acelyrin, inc.
2
Actinium pharmaceuticals, inc.
1
Acurx pharmaceuticals llc
2
Adverum biotechnologies, inc.
1
Aeon biopharma, inc.
1
Agba acquisition limited
1
Agnico eagle mines limited
1
Agrify corp
1
Akili inc
2
Akouos, inc.
1
Algernon pharmaceuticals inc.
1
Alibaba group holding limited
1
Aligos therapeutics, inc.
1
Alkermes plc
1
Alnylam pharmaceuticals, inc.
1
Altimmune, inc.
1
Alvotech lux holdings s.a.s.
1
Amalgamated bank
1
Amazon.com, inc.
1
Amgen inc.
1
Astrazeneca plc
2
Atai life sciences n.v.
2
Bridgebio pharma, inc.
2
Bristol-myers squibb company
5
Coherus biosciences, inc.
2
Dare bioscience, inc.
2
Eli lilly and company
3
Ensysce biosciences inc
2
Envveno medical corporation
2
Femasys inc
2
Gartner, inc.
4
Genprex, inc.
3
Ionis pharmaceuticals, inc.
5
Johnson & johnson
6
La rosa holdings corp.
2
Maia biotechnology, inc.
2
Matinas biopharma holdings, inc.
2
Moleculin biotech, inc.
2
Nasdaq, inc.
8
Neurosense therapeutics ltd.
3
Nexalin technology, inc.
2
Novartis ag
3
Ocugen, inc.
3
Ocular therapeutix, inc.
2
Orange
3
Parsons corporation
3
Petros pharmaceuticals inc
3
Pfizer, inc.
3
Phillips edison & company inc
2
Regenxbio inc.
3
Sagimet biosciences inc.
2
Sanofi
5
Sarepta therapeutics, inc.
2
Tonix pharmaceuticals holding corp.
5
Travere therapeutics inc.
2
Ultragenyx pharmaceutical inc.
2
Vertex pharmaceuticals incorporated
2
Zscaler, inc.
3
Symbols
ABBV
3
ACXP
2
ADVM
1
AEM
1
AEON
1
AGBA
1
AGFY
1
AGNPF
1
AKLI
2
AKUS
1
ALGS
1
ALKS
1
ALNY
1
ALPMF
1
ALPMY
1
ALT
1
ALVO
1
AMAL
1
AMGN
1
ATAI
2
AZN
2
BBIO
2
BMY
5
CHRS
2
DARE
2
ENSC
2
FEMY
2
FNCTF
3
GNPX
3
IONS
5
IT
4
JNJ
6
LLY
3
LRHC
2
MAIA
2
MBRX
2
MTNB
2
NDAQ
8
NRSN
3
NVNO
2
NVS
3
NVSEF
3
NXL
2
OCGN
3
OCUL
2
PECO
2
PFE
3
PSN
3
PTPI
3
RARE
2
RGNX
3
SGMT
2
SLRN
2
SNY
5
SNYNF
5
SRPT
2
TNXP
5
TVTX
2
VRTX
2
ZS
3
Exchanges
Amex
5
Nasdaq
262
Nyse
50
Crawled Date
2024 - 04 - 18
7
2024 - 04 - 16
4
2024 - 04 - 15
4
2024 - 04 - 11
4
2024 - 04 - 09
8
2024 - 04 - 08
7
2024 - 04 - 05
4
2024 - 04 - 04
5
2024 - 04 - 02
9
2024 - 04 - 01
6
2024 - 03 - 28
3
2024 - 03 - 27
5
2024 - 03 - 26
6
2024 - 03 - 25
8
2024 - 03 - 22
6
2024 - 03 - 20
4
2024 - 03 - 19
5
2024 - 03 - 18
2
2024 - 03 - 15
3
2024 - 03 - 14
4
2024 - 03 - 13
5
2024 - 03 - 12
6
2024 - 03 - 11
3
2024 - 03 - 07
6
2024 - 03 - 06
7
2024 - 03 - 05
9
2024 - 03 - 04
3
2024 - 02 - 29
3
2024 - 02 - 27
7
2024 - 02 - 26
5
2024 - 02 - 23
6
2024 - 02 - 22
7
2024 - 02 - 21
3
2024 - 02 - 15
3
2024 - 02 - 14
7
2024 - 02 - 13
2
2024 - 02 - 12
4
2024 - 02 - 08
5
2024 - 02 - 07
5
2024 - 02 - 06
3
2024 - 02 - 05
6
2024 - 02 - 02
2
2024 - 01 - 31
7
2024 - 01 - 30
6
2024 - 01 - 29
8
2024 - 01 - 26
2
2024 - 01 - 25
2
2024 - 01 - 24
2
2024 - 01 - 23
2
2024 - 01 - 22
4
2024 - 01 - 18
6
2024 - 01 - 17
4
2024 - 01 - 16
2
2024 - 01 - 11
3
2024 - 01 - 10
4
2024 - 01 - 09
4
2024 - 01 - 08
7
2024 - 01 - 04
5
2024 - 01 - 03
2
2024 - 01 - 02
3
Crawled Time
00:00
5
00:20
1
01:00
1
04:20
1
05:00
2
06:00
3
07:00
1
08:00
3
09:00
6
11:00
33
12:00
61
12:30
21
13:00
34
13:30
16
14:00
15
14:30
9
15:00
6
15:30
11
16:00
5
16:20
2
17:00
6
18:00
2
19:00
7
20:00
14
20:20
1
21:00
17
22:00
13
23:00
6
Source
e2open.com
1
hightideinc.com
1
immunitybio.com
1
neurosense.investorroom.com
2
parsons.com
1
spacfeed.com
1
www.biospace.com
69
www.globenewswire.com
171
www.hancockjaffe.com
1
www.prnewswire.com
54
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
positive
published :
This year
save search
Zscaler Positioned as a Leader in the 2024 Gartner® Magic Quadrant™ for Security Service Edge (SSE) for Third Straight Year
Published:
2024-04-18
(Crawled : 19:00)
- globenewswire.com
IT
|
News
|
$449.61
0.07%
0.0%
390K
|
Commercial Services
|
Email alert
Add to watchlist
ZS
|
News
|
$172.79
-0.1%
-0.1%
1.7M
|
Technology Services
|
Email alert
Add to watchlist
gartner
service
year
security
for
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
0.75%
|
O:
0.75%
H:
0.0%
C:
0.0%
rinvoq
positive
cell
results
study
LinkShadow is positioned as a Representative Vendor in the 2024 Gartner® Market Guide for Network Detection and Response (NDR)
Published:
2024-04-18
(Crawled : 14:00)
- prnewswire.com
IT
|
News
|
$449.61
0.07%
0.0%
390K
|
Commercial Services
|
-0.15%
|
O:
-0.15%
H:
0.0%
C:
0.0%
gartner
for
network
response
market
NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published:
2024-04-18
(Crawled : 13:00)
- neurosense.investorroom.com
NRSN
|
News
|
$1.51
-5.63%
-5.96%
270K
|
|
-5.0%
|
O:
-0.63%
H:
1.89%
C:
-4.4%
neurology
presentation
readout
positive
topline
meeting
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Published:
2024-04-18
(Crawled : 12:00)
- biospace.com/
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
|
36.67%
|
O:
5.41%
H:
41.06%
C:
29.66%
bb-301
first
positive
biopharma
for
trial
opmd
study
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
CERE
|
News
|
$42.16
1.35%
1.33%
1.3M
|
Finance
|
0.78%
|
O:
0.78%
H:
0.0%
C:
0.0%
disease
positive
for
topline
parkinson’s
trial
therapeutics
results
living
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
OCUL
|
News
|
$5.86
-22.69%
-29.35%
6.1M
|
Health Technology
|
-5.78%
|
O:
-5.78%
H:
0.0%
C:
0.0%
ocular
positive
for
topline
diabetic
Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
IMMP
|
News
|
$2.205
-2.43%
-2.73%
270K
|
Health Technology
|
-5.58%
|
O:
-6.87%
H:
0.0%
C:
0.0%
tacti-004
lung
positive
cancer
cell
for
trial
BranchOut Food Strengthens Financial Position with Successful Sale of Senior Secured Promissory Notes and Warrants
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
BOF
|
$1.1
-5.17%
-5.45%
5.6K
|
|
Email alert
Add to watchlist
food
financial
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
Published:
2024-04-16
(Crawled : 16:00)
- biospace.com/
PTPI
|
$0.69
0.0%
230K
|
|
-11.89%
|
O:
9.85%
H:
4.63%
C:
-18.04%
fda
positive
pharmaceuticals
for
technology
response
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
Published:
2024-04-16
(Crawled : 13:00)
- globenewswire.com
MYGN
F
|
$18.51
-0.7%
-0.7%
640K
|
Health Technology
|
-2.76%
|
O:
-2.61%
H:
0.0%
C:
0.0%
prequel
positive
for
study
Blue Biofuels Initiates Engineering and Design for Their CTS Commercial Plant Positioned to Produce Ethanol from Cellulosic Materials
Published:
2024-04-16
(Crawled : 12:00)
- globenewswire.com
BIOF
|
$0.0877
34.16%
80K
|
Information
|
6.29%
|
O:
0.36%
H:
6.02%
C:
5.9%
for
commercial
design
blue
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
ITCI
|
News
0 d
|
$72.01
-6.1%
-6.5%
4.7M
|
Health Technology
|
13.12%
|
O:
14.75%
H:
12.75%
C:
6.04%
positive
topline
therapy
results
study
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Published:
2024-04-15
(Crawled : 12:00)
- globenewswire.com
ONVO
|
$1.195
6.7%
6.28%
580K
|
Health Technology
|
10.88%
|
O:
64.34%
H:
4.82%
C:
-18.67%
fxr314
metabolic
liver
positive
for
results
Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
Published:
2024-04-15
(Crawled : 12:00)
- globenewswire.com
VIRX
|
$0.8971
-4.18%
-4.36%
79K
|
Manufacturing
|
-20.34%
|
O:
-12.71%
H:
0.97%
C:
-24.27%
t-cell
positive
topline
trial
therapeutics
results
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Published:
2024-04-15
(Crawled : 11:00)
- globenewswire.com
RARE
F
|
$43.38
-1.65%
-1.68%
770K
|
Health Technology
|
-11.65%
|
O:
-10.79%
H:
0.0%
C:
-3.75%
gtx-102
positive
treatment
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
Published:
2024-04-15
(Crawled : 11:00)
- globenewswire.com
TFFP
|
$3.2405
-9.69%
26K
|
Health Technology
|
-18.39%
|
O:
0.25%
H:
1.26%
C:
-11.56%
tacrolimus
presentation
positive
sessions
pharmaceuticals
trial
Vallen Distribution Announces Key Executive Leadership Positions
Published:
2024-04-11
(Crawled : 14:00)
- prnewswire.com
WCC
F
|
$153.44
0.6%
0.0%
510K
|
Distribution Services
|
-8.68%
|
O:
-0.62%
H:
0.0%
C:
0.0%
distribution
key
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published:
2024-04-11
(Crawled : 12:00)
- globenewswire.com
DARE
|
$0.299
5.77%
5.45%
970K
|
Health Technology
|
-37.32%
|
O:
1.36%
H:
0.68%
C:
-0.64%
ovaprene
test
positive
bioscience
publication
contraceptive
contraception
study
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
IPSC
|
$2.97
4.58%
4.38%
150K
|
Professional, Scientific, and T...
|
-26.04%
|
O:
3.39%
H:
11.53%
C:
2.02%
disease
million
pipeline
acquisition
expansion
therapeutics
← Previous
1
2
3
4
5
6
7
8
9
…
15
16
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.